Vivacta Biotechnology
Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases
$50MSeries A+
Role not disclosedCE
C&D Emerging Industry Equity Investment
Activity from announced rounds
Activity in this selectionjefferies-family-office-9ab84067
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $136.5M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionShengShu Technology
Develops multimodal foundation models for video generation and AI productivity
CN¥600MSeries A
Role not disclosed